1. Erlotinib: new drug. Non small-cell lung cancer: like gefitinib, no established advantage;Prescrire Int,2006
2. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer;Allen;Arch Neurol,2006
3. A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update;Biswas;Ecancermedicalscience,2008
4. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells;Biswas;Mol Vis,2009
5. Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy;Burris;J Clin Oncol,2011